Drugmakers Escape Cancer Drug Antitrust Claims For Now

By Jared Foretek · June 6, 2024, 9:01 PM EDT

A New Jersey federal judge granted drugmakers Celgene and Bristol-Myers Squibb an out from consolidated antitrust litigation accusing them of delaying generic competition to their blockbuster cancer treatments, saying the conduct...

To view the full article, register now.